http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104906067-B

Outgoing Links

Predicate Object
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-194
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-191
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14
filingDate 2014-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2017-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2017-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-104906067-B
titleOfInvention Ferrous composition of folic acid inclusion compound of a kind of stabilization and preparation method thereof and preparation
abstract The invention discloses ferrous composition of folic acid inclusion compound of a kind of stabilization and preparation method thereof and preparation.The ferrous composition of the folic acid inclusion compound of described stabilization is made up of 30 ~ 40 parts of folic acid inclusion compounds of parts by weight, 50 ~ 500 parts of ferrous salts, 185 ~ 550 parts of auxiliary materials.Described preparation method includes pretreatment, preparation process.Described preparation adds pharmaceutically acceptable auxiliary material for the ferrous composition of the folic acid inclusion compound of described stabilization and is prepared into powder, tablet, capsule, granule.The present composition and technology of preparing can significantly improve the stability of existing folic acid and acid of ferrous salt pref middle period, be adapted to industrial-scale production and application.
priorityDate 2014-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8535659-B1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447773061
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22836455
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450811345
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10464762
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559466
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559526
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419552576
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433322677
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553385
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24261
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457707758
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID402
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24393
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412228537
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449392821
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID136126080
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6433164
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154496863
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID27284
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559552
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398658
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5462224
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451814683
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID84571

Total number of triples: 44.